Business ❯ Corporate Governance ❯ Investor Relations ❯ Public Companies

Securities Regulations

Multiple Firms Seek Lead Role in Gossamer Bio Securities Suit After PROSERA Miss

Law firms say the company concealed trial‑design and site‑monitoring problems that plaintiffs blame for the failed Phase 3 result and heavy investor losses.

6 ARTICLES

6mo ago

MoonLake Faces Expanding Securities Suits as Lead-Plaintiff Deadline Nears